Literature DB >> 20707957

The acceptability of HPV vaccination among women attending the University of Saskatchewan Student Health Services.

Christopher Giede1, Laura Lee McFadden, Pam Komonoski, Anita Agrawal, Ardelle Stauffer, Roger Pierson.   

Abstract

OBJECTIVE: Women attending the University of Saskatchewan Student Health Services are being offered human papillomavirus (HPV) vaccination but are not filling their prescriptions. We sought to identify gaps in knowledge of the link between HPV infection, cervical dysplasia, and cervical cancer among women attending the Student Health Services, and to identify barriers to HPV vaccination among this cohort of women.
METHODS: Women attending the University of Saskatchewan Student Health Services for any reason were invited to complete an 18-question survey. The survey included questions regarding knowledge of the purpose of Pap smears, the role of HPV infection in cervical dysplasia and cancer, and HPV vaccination. The questions were designed to elicit both quantitative and qualitative data. Data analysis included basic descriptive analysis and summarization of qualitative data.
RESULTS: Four hundred surveys were distributed, and 371 (91%) were returned. Eighty-two percent of participants were aware of the HPV vaccine, and 40% ranked their knowledge of HPV as good or very good; however, only 6% correctly answered questions about methods of preventing HPV infection. Participants identified cost (62%), concerns over adverse effects (43%), and lack of knowledge (36%) as barriers to undergoing vaccination. Comments about the HPV vaccine reflected frustration with cost and concerns about adverse effects. When participants were asked if they would undergo vaccination if it were free, 60% responded "yes," 31% responded "maybe," and 8% responded "no."
CONCLUSION: The young women in our survey had significant gaps in knowledge of HPV infection and prevention, and educational programs must be structured to address these deficits. Institutions promoting vaccination must deal with the barriers of cost and fear of adverse effects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20707957     DOI: 10.1016/s1701-2163(16)34572-8

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  7 in total

1.  Knowledge, Attitudes and Barriers to Human Papillomavirus (HPV) Vaccine Uptake Among an Immigrant and Refugee Catch-Up Group in a Western Canadian Province.

Authors:  Erin McComb; Vivian Ramsden; Olufemi Olatunbosun; Hazel Williams-Roberts
Journal:  J Immigr Minor Health       Date:  2018-12

Review 2.  Have you ever heard of Human Papillomavirus (HPV) vaccine? The awareness of HPV vaccine for college students in China based on meta-analysis.

Authors:  Gang Yin; Yulin Zhang; Chaoyi Chen; Huayu Ren; Botang Guo; Meng Zhang
Journal:  Hum Vaccin Immunother       Date:  2021-03-31       Impact factor: 3.452

3.  Barriers to adult vaccination in Canada: A qualitative systematic review.

Authors:  Doris Stratoberdha; Barbara Gobis; Adrian Ziemczonek; Jamie Yuen; Annita Giang; Peter J Zed
Journal:  Can Pharm J (Ott)       Date:  2022-06-06

4.  Long-term effect of mobile phone-based education and influencing factors of willingness to receive HPV vaccination among female freshmen in Shanxi Province, China.

Authors:  Liying Sun; Jingjing Hu; Huihui Gao; Sunyi Wang; Binghan Wang; Jiawen Wang; Hui Li; Jianbing Wang; Changzheng Yuan; Xi Zhang
Journal:  Hum Vaccin Immunother       Date:  2022-04-21       Impact factor: 4.526

5.  Reasons for receiving or not receiving HPV vaccination in primary schoolgirls in Tanzania: a case control study.

Authors:  Deborah Watson-Jones; Keith Tomlin; Pieter Remes; Kathy Baisley; Riziki Ponsiano; Selephina Soteli; Silvia de Sanjosé; John Changalucha; Saidi Kapiga; Richard J Hayes
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

6.  Attitudes of undergraduate university women towards HPV vaccination: a cross-sectional study in Ottawa, Canada.

Authors:  Rachel Fernandes; Beth K Potter; Julian Little
Journal:  BMC Womens Health       Date:  2018-08-02       Impact factor: 2.809

7.  [Factors associated with scale-up human papillomavirus (HPV) vaccine in Senegal: a case-control survey of parents].

Authors:  Mbouna Ndiaye; Bernard Sawadogo; Ibrahima Sonko; Ibrahima Oumar Ba; Mamadou Makhtar Mbacke Leye
Journal:  Pan Afr Med J       Date:  2021-06-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.